Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

immune globulin subcutaneous human–klhw

A subcutaneous injectable formulation containing human immune globulins (Ig), mainly IgGs, with a broad spectrum of antibodies against bacterial, viral, parasitic, and mycoplasmal agents and their toxins, that can be used in the treatment of various primary humoral immunodeficiencies. Upon subcutaneous administration, immune globulin subcutaneous human provides a wide variety of opsonizing and neutralizing IgG antibodies, thereby restoring abnormally low IgG levels to normal concentrations and providing preventive activity against various infections.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	immune globulin subcutaneous human
US brand name:	Xembify
Abbreviation:	SCIG

immune globulin subcutaneous human–klhw

Search NCI's Drug Dictionary